je.st
news
J&J Hepatitis C Drug Wins U.S. Approval as Therapy With Sovaldi
2014-11-06 15:21:29| Food - Topix.net
Johnson & Johnson won U.S. approval for its hepatitis C drug Olysio to be used in combination with Gilead Sciences Inc.'s Sovaldi, making it the second all-oral treatment available for the most common form of the virus. The Food and Drug Administration cleared the once-daily treatment for patients with hepatitis C genotype 1, J&J said yesterday in a statement.
Tags: with
drug
approval
therapy
Category:Food and Related Products
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||